Marianna Alunni-Fabbroni

9PUBLICATIONS
23CO-AUTHORS
Predictive and prognostic markersCancer geneticsMedical virologyRadiation therapyLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 10, 2026
Cross-Cancer Circulating Proteins for the Prognosis of Primary and Metastatic Liver Cancer Treated with Local Ablation: Post Hoc Exploratory Analysis of the ESTIMATE Trial.

|Jul 09, 2025
Profiling of the tumor-associated microbiome in patients with hepatocellular carcinoma.

Christian Schulz, Ramiro Vilchez-Vargas, Elif Öcal

|Jul 19, 2023
Post-therapeutic microRNA-146a in liquid biopsies may determine prognosis in metastatic gastrointestinal cancer patients receiving 90Y-radioembolization.

Heidrun Hirner-Eppeneder, Elif Öcal, Matthias Stechele

|Jun 28, 2022
Extracellular Vesicles May Predict Response to Radioembolization and Sorafenib Treatment in Advanced Hepatocellular Carcinoma: An Exploratory Analysis from the SORAMIC Trial.

Timothy Wai Ho Shuen, Marianna Alunni-Fabbroni, Elif Öcal

|Oct 13, 2021
A Multi-Scale and Multi-Technique Approach for the Characterization of the Effects of Spatially Fractionated X-ray Radiation Therapies in a Preclinical Model.

Mariele Romano, Alberto Bravin, Alberto Mittone

|Jul 02, 2021
NMR-Based Lipid Metabolite Profiles to Predict Outcomes in Patients Undergoing Interventional Therapy for a Hepatocellular Carcinoma (HCC): A Substudy of the SORAMIC Trial.

Thomas Geyer, Johannes Rübenthaler, Marianna Alunni-Fabbroni

Pageof 2

Frequent Collaborators

2 joint publications

Jens Ricke

1 joint publications

Osman Öcal

1 joint publications

Johannes Rübenthaler

1 joint publications

Sabine Weber